Osaic Holdings
AUPH icon

Osaic Holdings’s Aurinia Pharmaceuticals AUPH Stock Holding History

Osaic Holdings’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Sell
21,174
-73
-0.3% -$1.17K ﹤0.01% 3957
2026
Q1 		$315K Buy
21,247
+329
+2% +$4.81K ﹤0.01% 3783
2025
Q4 		$334K Sell
20,918
-13,731
-40% -$195K ﹤0.01% 3700
2025
Q3 		$410K Sell
34,649
-28
-0.1% -$306 ﹤0.01% 3591
2025
Q2 		$294K Buy
34,677
+10,585
+44% +$84.8K ﹤0.01% 3618
2025
Q1 		$194K Sell
24,092
-20,939
-46% -$170K ﹤0.01% 3656
2024
Q4 		$404K Buy
45,031
+19,916
+79% +$162K ﹤0.01% 2978
2024
Q3 		$184K Buy
25,115
+14,269
+132% +$88.5K ﹤0.01% 3718
2024
Q2 		$61.9K Sell
10,846
-412
-4% -$2.17K ﹤0.01% 4510
2024
Q1 		$56.4K Sell
11,258
-5,348
-32% -$36.3K ﹤0.01% 4663
2023
Q4 		$149K Buy
16,606
+96
+0.6% +$791 ﹤0.01% 4154
2023
Q3 		$128K Buy
16,510
+2,813
+21% +$27.5K ﹤0.01% 4314
2023
Q2 		$133K Buy
13,697
+5,964
+77% +$61.9K ﹤0.01% 4231
2023
Q1 		$84.8K Sell
7,733
-3,743
-33% -$33K ﹤0.01% 4570
2022
Q4 		$49.7K Sell
11,476
-1,153
-9% -$6.69K ﹤0.01% 4942
2022
Q3 		$95K Sell
12,629
-4,190
-25% -$36.3K ﹤0.01% 4423
2022
Q2 		$168K Sell
16,819
-1,674
-9% -$18.7K ﹤0.01% 3951
2022
Q1 		$228K Sell
18,493
-1,493
-7% -$23.1K ﹤0.01% 3914
2021
Q4 		$455K Buy
19,986
+2,096
+12% +$49.7K ﹤0.01% 3155
2021
Q3 		$395K Sell
17,890
-16,469
-48% -$261K ﹤0.01% 3276
2021
Q2 		$444K Buy
34,359
+14,946
+77% +$190K ﹤0.01% 3146
2021
Q1 		$253K Sell
19,413
-25,978
-57% -$377K ﹤0.01% 3532
2020
Q4 		$628K Buy
45,391
+26,061
+135% +$379K ﹤0.01% 2435
2020
Q3 		$285K Buy
19,330
+2,300
+14% +$33.3K ﹤0.01% 2924
2020
Q2 		$277K Buy
17,030
+9,830
+137% +$157K ﹤0.01% 2848
2020
Q1 		$104K Buy
+7,200
New +$127K ﹤0.01% 3441

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's AUPH Position: Q2 2026 in Review

Osaic Holdings reduced its Aurinia Pharmaceuticals (AUPH) stake by 0.34% in Q2 2026, selling an estimated $1.17K and leaving 21,174 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #3957.

Osaic Holdings first reported a position in AUPH in Q1 2020 and has held it in 26 quarters since. The position peaked at $628K in Q4 2020. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Osaic Holdings held 21,174 shares of Aurinia Pharmaceuticals worth $359K as of Q2 2026.
  • Osaic Holdings sold 73 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $1.17K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3957 holding.
  • Osaic Holdings first reported a position in Aurinia Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Aurinia Pharmaceuticals position peaked at $628K in Q4 2020.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.